Hemostasis Today highlighted GeneVentiv’s scientific debut at ASGCT 2026.
The coverage features Damon Race’s update on GeneVentiv’s presentation of its next-generation AAV8.FVa work in hemophilia A with or without inhibitors, including the program’s focus on native hepatic expression of a regulated coagulation cofactor.